Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.

[1]  F. Mutinelli,et al.  Expression of Ki67, BCL-2, and COX-2 in Canine Cutaneous Mast Cell Tumors , 2013, Veterinary pathology.

[2]  J D Webster,et al.  Proposal of a 2-Tier Histologic Grading System for Canine Cutaneous Mast Cell Tumors to More Accurately Predict Biological Behavior , 2011, Veterinary pathology.

[3]  J. Webster,et al.  Recommended Guidelines for the Conduct and Evaluation of Prognostic Studies in Veterinary Oncology , 2011, Veterinary pathology.

[4]  S. Sugano,et al.  Aberrant autophosphorylation of c-Kit receptor in canine mast cell tumor cell lines. , 2010, Veterinary immunology and immunopathology.

[5]  F. Shofer,et al.  Cytological lymph node evaluation in dogs with mast cell tumours: association with grade and survival. , 2009, Veterinary and comparative oncology.

[6]  M. Welle,et al.  Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment. , 2008, Veterinary dermatology.

[7]  H. Tsujimoto,et al.  Identification of c-kit mutations-independent neoplastic cell proliferation of canine mast cells. , 2008, Veterinary immunology and immunopathology.

[8]  J. Webster,et al.  Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone , 2008, BMC veterinary research.

[9]  R. Kato,et al.  Effect of tyrosine kinase inhibition by imatinib mesylate on mast cell tumors in dogs. , 2008, Journal of veterinary internal medicine.

[10]  J. Kinet,et al.  Gain-of-Function Mutations in the Extracellular Domain of KIT Are Common in Canine Mast Cell Tumors , 2008, Molecular Cancer Research.

[11]  T. Scase,et al.  Advances in the diagnosis and management of cutaneous mast cell tumours in dogs. , 2007, The Journal of small animal practice.

[12]  G. Sarli,et al.  Multivariate Survival Analysis of Histological Parameters and Clinical Presentation in Canine Cutaneous Mast Cell Tumours , 2007, Veterinary Research Communications.

[13]  J. Webster,et al.  Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors , 2006, BMC Cancer.

[14]  J. Resau,et al.  The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors. , 2006, Neoplasia.

[15]  R. Roskoski.  Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor. , 2005, Biochemical and biophysical research communications.

[16]  J. Munday,et al.  Variation among Pathologists in the Histologic Grading of Canine Cutaneous Mast Cell Tumors with Uniform Use of a Single Grading Reference , 2005, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[17]  J. Webster,et al.  The Use of KIT and Tryptase Expression Patterns as Prognostic Tools for Canine Cutaneous Mast Cell Tumors , 2004, Veterinary pathology.

[18]  K. Smith,et al.  Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection , 2004, Veterinary Record.

[19]  R. Guyon,et al.  Identification of isoforms and RH mapping of canine KIT , 2004, Cytogenetic and Genome Research.

[20]  N. Pryer,et al.  Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  J. Catão-Dias,et al.  Morphometry of Canine Cutaneous Mast Cell Tumors , 2003, Veterinary pathology.

[22]  C. London,et al.  Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs. , 2002, American journal of veterinary research.

[23]  V. Yuzbasiyan-Gurkan,et al.  Mutations in the Juxtamembrane Domain of c-KIT Are Associated with Higher Grade Mast Cell Tumors in Dogs , 2002, Veterinary pathology.

[24]  S. Galli,et al.  Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit. , 1999, Experimental hematology.

[25]  Y. Ma,et al.  Clustering of activating mutations in c-KIT's juxtamembrane coding region in canine mast cell neoplasms. , 1999, The Journal of investigative dermatology.

[26]  E. Macewen,et al.  Canine Cutaneous Mast Cell Tumor: Morphologic Grading and Survival Time in 83 Dogs , 1984, Veterinary pathology.

[27]  S. Murphy,et al.  Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis. , 2006, Journal of veterinary internal medicine.

[28]  David M. Vail.  Mast cell tumors , 1996 .